nodes	percent_of_prediction	percent_of_DWPC	metapath
Ixabepilone—Renal failure—Sorafenib—liver cancer	0.00298	0.00508	CcSEcCtD
Ixabepilone—Neuropathy peripheral—Sorafenib—liver cancer	0.00297	0.00506	CcSEcCtD
Ixabepilone—Myocardial infarction—Sorafenib—liver cancer	0.00297	0.00506	CcSEcCtD
Ixabepilone—Stomatitis—Sorafenib—liver cancer	0.00295	0.00504	CcSEcCtD
Ixabepilone—Jaundice—Sorafenib—liver cancer	0.00295	0.00504	CcSEcCtD
Ixabepilone—Embolism—Doxorubicin—liver cancer	0.00289	0.00492	CcSEcCtD
Ixabepilone—Neuralgia—Epirubicin—liver cancer	0.00288	0.00491	CcSEcCtD
Ixabepilone—Burning sensation—Epirubicin—liver cancer	0.00288	0.00491	CcSEcCtD
Ixabepilone—Hepatobiliary disease—Sorafenib—liver cancer	0.00287	0.00489	CcSEcCtD
Ixabepilone—Nail disorder—Doxorubicin—liver cancer	0.00286	0.00487	CcSEcCtD
Ixabepilone—Thrombosis—Epirubicin—liver cancer	0.00283	0.00482	CcSEcCtD
Ixabepilone—Ileus—Epirubicin—liver cancer	0.00283	0.00482	CcSEcCtD
Ixabepilone—Laryngitis—Epirubicin—liver cancer	0.00278	0.00474	CcSEcCtD
Ixabepilone—Haemoglobin—Sorafenib—liver cancer	0.00273	0.00466	CcSEcCtD
Ixabepilone—Haemorrhage—Sorafenib—liver cancer	0.00272	0.00464	CcSEcCtD
Ixabepilone—Urinary tract disorder—Sorafenib—liver cancer	0.00269	0.00458	CcSEcCtD
Ixabepilone—Neuritis—Epirubicin—liver cancer	0.00268	0.00457	CcSEcCtD
Ixabepilone—Connective tissue disorder—Sorafenib—liver cancer	0.00267	0.00456	CcSEcCtD
Ixabepilone—Urethral disorder—Sorafenib—liver cancer	0.00267	0.00455	CcSEcCtD
Ixabepilone—Neuralgia—Doxorubicin—liver cancer	0.00267	0.00455	CcSEcCtD
Ixabepilone—Burning sensation—Doxorubicin—liver cancer	0.00267	0.00455	CcSEcCtD
Ixabepilone—Thrombosis—Doxorubicin—liver cancer	0.00262	0.00446	CcSEcCtD
Ixabepilone—Ileus—Doxorubicin—liver cancer	0.00262	0.00446	CcSEcCtD
Ixabepilone—Erythema multiforme—Sorafenib—liver cancer	0.00257	0.00439	CcSEcCtD
Ixabepilone—Laryngitis—Doxorubicin—liver cancer	0.00257	0.00438	CcSEcCtD
Ixabepilone—Hyperaesthesia—Epirubicin—liver cancer	0.00255	0.00435	CcSEcCtD
Ixabepilone—Cardiac disorder—Sorafenib—liver cancer	0.00252	0.0043	CcSEcCtD
Ixabepilone—Neuritis—Doxorubicin—liver cancer	0.00248	0.00423	CcSEcCtD
Ixabepilone—Angiopathy—Sorafenib—liver cancer	0.00247	0.00421	CcSEcCtD
Ixabepilone—Immune system disorder—Sorafenib—liver cancer	0.00246	0.00419	CcSEcCtD
Ixabepilone—Mediastinal disorder—Sorafenib—liver cancer	0.00245	0.00418	CcSEcCtD
Ixabepilone—Dysphonia—Epirubicin—liver cancer	0.00243	0.00415	CcSEcCtD
Ixabepilone—Alopecia—Sorafenib—liver cancer	0.0024	0.0041	CcSEcCtD
Ixabepilone—Mental disorder—Sorafenib—liver cancer	0.00238	0.00406	CcSEcCtD
Ixabepilone—Malnutrition—Sorafenib—liver cancer	0.00237	0.00404	CcSEcCtD
Ixabepilone—Hyperaesthesia—Doxorubicin—liver cancer	0.00236	0.00402	CcSEcCtD
Ixabepilone—Muscle spasms—Sorafenib—liver cancer	0.00228	0.00388	CcSEcCtD
Ixabepilone—Dysphonia—Doxorubicin—liver cancer	0.00225	0.00384	CcSEcCtD
Ixabepilone—Bone disorder—Epirubicin—liver cancer	0.00222	0.00378	CcSEcCtD
Ixabepilone—Anaemia—Sorafenib—liver cancer	0.00219	0.00373	CcSEcCtD
Ixabepilone—Lacrimation increased—Epirubicin—liver cancer	0.00217	0.0037	CcSEcCtD
Ixabepilone—Syncope—Sorafenib—liver cancer	0.00212	0.00362	CcSEcCtD
Ixabepilone—Leukopenia—Sorafenib—liver cancer	0.00212	0.00361	CcSEcCtD
Ixabepilone—Loss of consciousness—Sorafenib—liver cancer	0.00208	0.00355	CcSEcCtD
Ixabepilone—Cough—Sorafenib—liver cancer	0.00207	0.00352	CcSEcCtD
Ixabepilone—Bone disorder—Doxorubicin—liver cancer	0.00205	0.0035	CcSEcCtD
Ixabepilone—Coordination abnormal—Epirubicin—liver cancer	0.00204	0.00348	CcSEcCtD
Ixabepilone—Musculoskeletal pain—Epirubicin—liver cancer	0.00203	0.00345	CcSEcCtD
Ixabepilone—Myalgia—Sorafenib—liver cancer	0.00202	0.00344	CcSEcCtD
Ixabepilone—Arthralgia—Sorafenib—liver cancer	0.00202	0.00344	CcSEcCtD
Ixabepilone—Lacrimation increased—Doxorubicin—liver cancer	0.00201	0.00343	CcSEcCtD
Ixabepilone—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—liver cancer	0.002	0.00341	CcSEcCtD
Ixabepilone—Colitis—Epirubicin—liver cancer	0.00192	0.00328	CcSEcCtD
Ixabepilone—Infection—Sorafenib—liver cancer	0.00192	0.00327	CcSEcCtD
Ixabepilone—Skin exfoliation—Epirubicin—liver cancer	0.00191	0.00326	CcSEcCtD
Ixabepilone—Shock—Sorafenib—liver cancer	0.0019	0.00324	CcSEcCtD
Ixabepilone—Nervous system disorder—Sorafenib—liver cancer	0.0019	0.00323	CcSEcCtD
Ixabepilone—Thrombocytopenia—Sorafenib—liver cancer	0.00189	0.00323	CcSEcCtD
Ixabepilone—Coordination abnormal—Doxorubicin—liver cancer	0.00189	0.00322	CcSEcCtD
Ixabepilone—Neuropathy—Epirubicin—liver cancer	0.00188	0.0032	CcSEcCtD
Ixabepilone—Skin disorder—Sorafenib—liver cancer	0.00188	0.0032	CcSEcCtD
Ixabepilone—Musculoskeletal pain—Doxorubicin—liver cancer	0.00187	0.0032	CcSEcCtD
Ixabepilone—Anorexia—Sorafenib—liver cancer	0.00184	0.00314	CcSEcCtD
Ixabepilone—Oesophagitis—Epirubicin—liver cancer	0.00183	0.00312	CcSEcCtD
Ixabepilone—Colitis—Doxorubicin—liver cancer	0.00178	0.00303	CcSEcCtD
Ixabepilone—Skin exfoliation—Doxorubicin—liver cancer	0.00177	0.00302	CcSEcCtD
Ixabepilone—Musculoskeletal discomfort—Sorafenib—liver cancer	0.00176	0.003	CcSEcCtD
Ixabepilone—Neuropathy—Doxorubicin—liver cancer	0.00174	0.00297	CcSEcCtD
Ixabepilone—Sepsis—Epirubicin—liver cancer	0.00174	0.00296	CcSEcCtD
Ixabepilone—Dyspnoea—Sorafenib—liver cancer	0.00172	0.00294	CcSEcCtD
Ixabepilone—Oesophagitis—Doxorubicin—liver cancer	0.00169	0.00289	CcSEcCtD
Ixabepilone—Decreased appetite—Sorafenib—liver cancer	0.00168	0.00286	CcSEcCtD
Ixabepilone—Gastrointestinal disorder—Sorafenib—liver cancer	0.00167	0.00284	CcSEcCtD
Ixabepilone—Fatigue—Sorafenib—liver cancer	0.00167	0.00284	CcSEcCtD
Ixabepilone—Constipation—Sorafenib—liver cancer	0.00165	0.00282	CcSEcCtD
Ixabepilone—Pain—Sorafenib—liver cancer	0.00165	0.00282	CcSEcCtD
Ixabepilone—Sepsis—Doxorubicin—liver cancer	0.00161	0.00274	CcSEcCtD
Ixabepilone—Gastrointestinal pain—Sorafenib—liver cancer	0.00158	0.00269	CcSEcCtD
Ixabepilone—Hot flush—Epirubicin—liver cancer	0.00155	0.00265	CcSEcCtD
Ixabepilone—Menopausal symptoms—Epirubicin—liver cancer	0.00154	0.00263	CcSEcCtD
Ixabepilone—Abdominal pain—Sorafenib—liver cancer	0.00153	0.0026	CcSEcCtD
Ixabepilone—Body temperature increased—Sorafenib—liver cancer	0.00153	0.0026	CcSEcCtD
Ixabepilone—Lethargy—Epirubicin—liver cancer	0.00148	0.00253	CcSEcCtD
Ixabepilone—Hyponatraemia—Epirubicin—liver cancer	0.00146	0.00249	CcSEcCtD
Ixabepilone—Gastrointestinal haemorrhage—Epirubicin—liver cancer	0.00145	0.00248	CcSEcCtD
Ixabepilone—Hot flush—Doxorubicin—liver cancer	0.00144	0.00245	CcSEcCtD
Ixabepilone—Menopausal symptoms—Doxorubicin—liver cancer	0.00142	0.00243	CcSEcCtD
Ixabepilone—Hypersensitivity—Sorafenib—liver cancer	0.00142	0.00243	CcSEcCtD
Ixabepilone—Asthenia—Sorafenib—liver cancer	0.00139	0.00236	CcSEcCtD
Ixabepilone—Lethargy—Doxorubicin—liver cancer	0.00137	0.00234	CcSEcCtD
Ixabepilone—Pruritus—Sorafenib—liver cancer	0.00137	0.00233	CcSEcCtD
Ixabepilone—Dehydration—Epirubicin—liver cancer	0.00135	0.0023	CcSEcCtD
Ixabepilone—Hyponatraemia—Doxorubicin—liver cancer	0.00135	0.0023	CcSEcCtD
Ixabepilone—Gastrointestinal haemorrhage—Doxorubicin—liver cancer	0.00134	0.00229	CcSEcCtD
Ixabepilone—Hypokalaemia—Epirubicin—liver cancer	0.00132	0.00225	CcSEcCtD
Ixabepilone—Diarrhoea—Sorafenib—liver cancer	0.00132	0.00225	CcSEcCtD
Ixabepilone—Gastritis—Epirubicin—liver cancer	0.00129	0.00219	CcSEcCtD
Ixabepilone—Muscular weakness—Epirubicin—liver cancer	0.00128	0.00219	CcSEcCtD
Ixabepilone—Dizziness—Sorafenib—liver cancer	0.00128	0.00218	CcSEcCtD
Ixabepilone—Dysphagia—Epirubicin—liver cancer	0.00126	0.00214	CcSEcCtD
Ixabepilone—Dehydration—Doxorubicin—liver cancer	0.00125	0.00213	CcSEcCtD
Ixabepilone—Vomiting—Sorafenib—liver cancer	0.00123	0.0021	CcSEcCtD
Ixabepilone—Hypokalaemia—Doxorubicin—liver cancer	0.00122	0.00209	CcSEcCtD
Ixabepilone—Angina pectoris—Epirubicin—liver cancer	0.00122	0.00209	CcSEcCtD
Ixabepilone—Rash—Sorafenib—liver cancer	0.00122	0.00208	CcSEcCtD
Ixabepilone—Dermatitis—Sorafenib—liver cancer	0.00122	0.00208	CcSEcCtD
Ixabepilone—Headache—Sorafenib—liver cancer	0.00121	0.00206	CcSEcCtD
Ixabepilone—Pancytopenia—Epirubicin—liver cancer	0.00119	0.00203	CcSEcCtD
Ixabepilone—Gastritis—Doxorubicin—liver cancer	0.00119	0.00203	CcSEcCtD
Ixabepilone—Muscular weakness—Doxorubicin—liver cancer	0.00119	0.00202	CcSEcCtD
Ixabepilone—Neutropenia—Epirubicin—liver cancer	0.00117	0.002	CcSEcCtD
Ixabepilone—Upper respiratory tract infection—Epirubicin—liver cancer	0.00117	0.00199	CcSEcCtD
Ixabepilone—Dysphagia—Doxorubicin—liver cancer	0.00116	0.00198	CcSEcCtD
Ixabepilone—Nausea—Sorafenib—liver cancer	0.00115	0.00196	CcSEcCtD
Ixabepilone—Weight decreased—Epirubicin—liver cancer	0.00114	0.00194	CcSEcCtD
Ixabepilone—Angina pectoris—Doxorubicin—liver cancer	0.00113	0.00193	CcSEcCtD
Ixabepilone—Pneumonia—Epirubicin—liver cancer	0.00113	0.00192	CcSEcCtD
Ixabepilone—Infestation NOS—Epirubicin—liver cancer	0.00112	0.00191	CcSEcCtD
Ixabepilone—Infestation—Epirubicin—liver cancer	0.00112	0.00191	CcSEcCtD
Ixabepilone—Pancytopenia—Doxorubicin—liver cancer	0.0011	0.00188	CcSEcCtD
Ixabepilone—Renal failure—Epirubicin—liver cancer	0.0011	0.00188	CcSEcCtD
Ixabepilone—Neuropathy peripheral—Epirubicin—liver cancer	0.0011	0.00187	CcSEcCtD
Ixabepilone—Jaundice—Epirubicin—liver cancer	0.00109	0.00186	CcSEcCtD
Ixabepilone—Stomatitis—Epirubicin—liver cancer	0.00109	0.00186	CcSEcCtD
Ixabepilone—Urinary tract infection—Epirubicin—liver cancer	0.00109	0.00186	CcSEcCtD
Ixabepilone—Neutropenia—Doxorubicin—liver cancer	0.00109	0.00185	CcSEcCtD
Ixabepilone—Upper respiratory tract infection—Doxorubicin—liver cancer	0.00108	0.00184	CcSEcCtD
Ixabepilone—Hepatobiliary disease—Epirubicin—liver cancer	0.00106	0.00181	CcSEcCtD
Ixabepilone—Weight decreased—Doxorubicin—liver cancer	0.00105	0.00179	CcSEcCtD
Ixabepilone—Pneumonia—Doxorubicin—liver cancer	0.00104	0.00178	CcSEcCtD
Ixabepilone—Infestation NOS—Doxorubicin—liver cancer	0.00104	0.00177	CcSEcCtD
Ixabepilone—Infestation—Doxorubicin—liver cancer	0.00104	0.00177	CcSEcCtD
Ixabepilone—Renal failure—Doxorubicin—liver cancer	0.00102	0.00174	CcSEcCtD
Ixabepilone—Neuropathy peripheral—Doxorubicin—liver cancer	0.00102	0.00173	CcSEcCtD
Ixabepilone—Haemoglobin—Epirubicin—liver cancer	0.00101	0.00172	CcSEcCtD
Ixabepilone—Jaundice—Doxorubicin—liver cancer	0.00101	0.00172	CcSEcCtD
Ixabepilone—Stomatitis—Doxorubicin—liver cancer	0.00101	0.00172	CcSEcCtD
Ixabepilone—Urinary tract infection—Doxorubicin—liver cancer	0.00101	0.00172	CcSEcCtD
Ixabepilone—Haemorrhage—Epirubicin—liver cancer	0.00101	0.00171	CcSEcCtD
Ixabepilone—Hypoaesthesia—Epirubicin—liver cancer	0.001	0.00171	CcSEcCtD
Ixabepilone—Urinary tract disorder—Epirubicin—liver cancer	0.000993	0.00169	CcSEcCtD
Ixabepilone—Connective tissue disorder—Epirubicin—liver cancer	0.000988	0.00168	CcSEcCtD
Ixabepilone—Urethral disorder—Epirubicin—liver cancer	0.000985	0.00168	CcSEcCtD
Ixabepilone—Hepatobiliary disease—Doxorubicin—liver cancer	0.00098	0.00167	CcSEcCtD
Ixabepilone—Erythema multiforme—Epirubicin—liver cancer	0.000951	0.00162	CcSEcCtD
Ixabepilone—Eye disorder—Epirubicin—liver cancer	0.000939	0.0016	CcSEcCtD
Ixabepilone—Haemoglobin—Doxorubicin—liver cancer	0.000935	0.00159	CcSEcCtD
Ixabepilone—Cardiac disorder—Epirubicin—liver cancer	0.000933	0.00159	CcSEcCtD
Ixabepilone—Haemorrhage—Doxorubicin—liver cancer	0.00093	0.00159	CcSEcCtD
Ixabepilone—Hypoaesthesia—Doxorubicin—liver cancer	0.000926	0.00158	CcSEcCtD
Ixabepilone—Urinary tract disorder—Doxorubicin—liver cancer	0.000919	0.00157	CcSEcCtD
Ixabepilone—Connective tissue disorder—Doxorubicin—liver cancer	0.000914	0.00156	CcSEcCtD
Ixabepilone—Angiopathy—Epirubicin—liver cancer	0.000912	0.00156	CcSEcCtD
Ixabepilone—Urethral disorder—Doxorubicin—liver cancer	0.000912	0.00155	CcSEcCtD
Ixabepilone—Immune system disorder—Epirubicin—liver cancer	0.000908	0.00155	CcSEcCtD
Ixabepilone—Mediastinal disorder—Epirubicin—liver cancer	0.000906	0.00154	CcSEcCtD
Ixabepilone—Chills—Epirubicin—liver cancer	0.000902	0.00154	CcSEcCtD
Ixabepilone—Alopecia—Epirubicin—liver cancer	0.000888	0.00151	CcSEcCtD
Ixabepilone—Mental disorder—Epirubicin—liver cancer	0.000881	0.0015	CcSEcCtD
Ixabepilone—Erythema multiforme—Doxorubicin—liver cancer	0.000879	0.0015	CcSEcCtD
Ixabepilone—Malnutrition—Epirubicin—liver cancer	0.000875	0.00149	CcSEcCtD
Ixabepilone—Eye disorder—Doxorubicin—liver cancer	0.000869	0.00148	CcSEcCtD
Ixabepilone—Cardiac disorder—Doxorubicin—liver cancer	0.000863	0.00147	CcSEcCtD
Ixabepilone—Angiopathy—Doxorubicin—liver cancer	0.000844	0.00144	CcSEcCtD
Ixabepilone—Muscle spasms—Epirubicin—liver cancer	0.000841	0.00143	CcSEcCtD
Ixabepilone—Immune system disorder—Doxorubicin—liver cancer	0.00084	0.00143	CcSEcCtD
Ixabepilone—Mediastinal disorder—Doxorubicin—liver cancer	0.000838	0.00143	CcSEcCtD
Ixabepilone—Chills—Doxorubicin—liver cancer	0.000835	0.00142	CcSEcCtD
Ixabepilone—Alopecia—Doxorubicin—liver cancer	0.000822	0.0014	CcSEcCtD
Ixabepilone—TUBB6—Metabolism of proteins—EXOSC2—liver cancer	0.000818	0.00198	CbGpPWpGaD
Ixabepilone—TUBB2B—Metabolism of proteins—EXOSC2—liver cancer	0.000818	0.00198	CbGpPWpGaD
Ixabepilone—TUBB4A—Metabolism of proteins—YIF1A—liver cancer	0.000816	0.00197	CbGpPWpGaD
Ixabepilone—Mental disorder—Doxorubicin—liver cancer	0.000815	0.00139	CcSEcCtD
Ixabepilone—Malnutrition—Doxorubicin—liver cancer	0.00081	0.00138	CcSEcCtD
Ixabepilone—CYP3A4—Tamoxifen metabolism—CYP2E1—liver cancer	0.000809	0.00196	CbGpPWpGaD
Ixabepilone—Anaemia—Epirubicin—liver cancer	0.000809	0.00138	CcSEcCtD
Ixabepilone—CYP3A4—Aflatoxin activation and detoxification—GGT1—liver cancer	0.000805	0.00195	CbGpPWpGaD
Ixabepilone—TUBB3—Transmembrane transport of small molecules—SLC11A2—liver cancer	0.000801	0.00194	CbGpPWpGaD
Ixabepilone—TUBB6—Transmembrane transport of small molecules—SLC40A1—liver cancer	0.000791	0.00191	CbGpPWpGaD
Ixabepilone—TUBB2B—Transmembrane transport of small molecules—SLC40A1—liver cancer	0.000791	0.00191	CbGpPWpGaD
Ixabepilone—TUBB3—Metabolism of proteins—EXOSC2—liver cancer	0.00079	0.00191	CbGpPWpGaD
Ixabepilone—TUBB4B—Orphan transporters—PPARA—liver cancer	0.000789	0.00191	CbGpPWpGaD
Ixabepilone—Syncope—Epirubicin—liver cancer	0.000785	0.00134	CcSEcCtD
Ixabepilone—Leukopenia—Epirubicin—liver cancer	0.000783	0.00134	CcSEcCtD
Ixabepilone—Muscle spasms—Doxorubicin—liver cancer	0.000779	0.00133	CcSEcCtD
Ixabepilone—TUBB2A—Transmembrane transport of small molecules—SLC11A2—liver cancer	0.000775	0.00187	CbGpPWpGaD
Ixabepilone—Loss of consciousness—Epirubicin—liver cancer	0.000769	0.00131	CcSEcCtD
Ixabepilone—TUBB2A—Metabolism of proteins—EXOSC2—liver cancer	0.000766	0.00185	CbGpPWpGaD
Ixabepilone—TUBB4B—Pathogenic Escherichia coli infection—CTNNB1—liver cancer	0.000765	0.00185	CbGpPWpGaD
Ixabepilone—TUBB3—Transmembrane transport of small molecules—SLC40A1—liver cancer	0.000764	0.00185	CbGpPWpGaD
Ixabepilone—Cough—Epirubicin—liver cancer	0.000764	0.0013	CcSEcCtD
Ixabepilone—TUBB2B—Transmembrane transport of small molecules—ANXA2—liver cancer	0.000758	0.00183	CbGpPWpGaD
Ixabepilone—TUBB6—Transmembrane transport of small molecules—ANXA2—liver cancer	0.000758	0.00183	CbGpPWpGaD
Ixabepilone—TUBB2B—Transmembrane transport of small molecules—ATP7B—liver cancer	0.000758	0.00183	CbGpPWpGaD
Ixabepilone—TUBB6—Transmembrane transport of small molecules—ATP7B—liver cancer	0.000758	0.00183	CbGpPWpGaD
Ixabepilone—TUBB1—Transmembrane transport of small molecules—SLC11A2—liver cancer	0.000758	0.00183	CbGpPWpGaD
Ixabepilone—TUBB1—Metabolism of proteins—EXOSC2—liver cancer	0.000749	0.00181	CbGpPWpGaD
Ixabepilone—Anaemia—Doxorubicin—liver cancer	0.000748	0.00128	CcSEcCtD
Ixabepilone—TUBB4B—Metabolism of proteins—YIF1A—liver cancer	0.000746	0.00181	CbGpPWpGaD
Ixabepilone—Myalgia—Epirubicin—liver cancer	0.000745	0.00127	CcSEcCtD
Ixabepilone—Arthralgia—Epirubicin—liver cancer	0.000745	0.00127	CcSEcCtD
Ixabepilone—Chest pain—Epirubicin—liver cancer	0.000745	0.00127	CcSEcCtD
Ixabepilone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.00074	0.00126	CcSEcCtD
Ixabepilone—TUBB2A—Transmembrane transport of small molecules—SLC40A1—liver cancer	0.00074	0.00179	CbGpPWpGaD
Ixabepilone—TUBB3—Transmembrane transport of small molecules—ANXA2—liver cancer	0.000732	0.00177	CbGpPWpGaD
Ixabepilone—TUBB3—Transmembrane transport of small molecules—ATP7B—liver cancer	0.000732	0.00177	CbGpPWpGaD
Ixabepilone—Syncope—Doxorubicin—liver cancer	0.000726	0.00124	CcSEcCtD
Ixabepilone—Leukopenia—Doxorubicin—liver cancer	0.000725	0.00124	CcSEcCtD
Ixabepilone—TUBB1—Transmembrane transport of small molecules—SLC40A1—liver cancer	0.000723	0.00175	CbGpPWpGaD
Ixabepilone—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—liver cancer	0.000722	0.00175	CbGpPWpGaD
Ixabepilone—TUBB2B—Transmembrane transport of small molecules—NR1H4—liver cancer	0.000717	0.00173	CbGpPWpGaD
Ixabepilone—TUBB6—Transmembrane transport of small molecules—NR1H4—liver cancer	0.000717	0.00173	CbGpPWpGaD
Ixabepilone—Oedema—Epirubicin—liver cancer	0.000714	0.00122	CcSEcCtD
Ixabepilone—Loss of consciousness—Doxorubicin—liver cancer	0.000712	0.00121	CcSEcCtD
Ixabepilone—Infection—Epirubicin—liver cancer	0.00071	0.00121	CcSEcCtD
Ixabepilone—TUBB2A—Transmembrane transport of small molecules—ANXA2—liver cancer	0.000709	0.00171	CbGpPWpGaD
Ixabepilone—TUBB2A—Transmembrane transport of small molecules—ATP7B—liver cancer	0.000709	0.00171	CbGpPWpGaD
Ixabepilone—Cough—Doxorubicin—liver cancer	0.000707	0.0012	CcSEcCtD
Ixabepilone—Shock—Epirubicin—liver cancer	0.000703	0.0012	CcSEcCtD
Ixabepilone—Nervous system disorder—Epirubicin—liver cancer	0.0007	0.00119	CcSEcCtD
Ixabepilone—Thrombocytopenia—Epirubicin—liver cancer	0.000699	0.00119	CcSEcCtD
Ixabepilone—Skin disorder—Epirubicin—liver cancer	0.000694	0.00118	CcSEcCtD
Ixabepilone—CYP3A4—Estrogen metabolism—GSTM1—liver cancer	0.000694	0.00168	CbGpPWpGaD
Ixabepilone—TUBB1—Transmembrane transport of small molecules—ATP7B—liver cancer	0.000693	0.00168	CbGpPWpGaD
Ixabepilone—TUBB1—Transmembrane transport of small molecules—ANXA2—liver cancer	0.000693	0.00168	CbGpPWpGaD
Ixabepilone—TUBB3—Transmembrane transport of small molecules—NR1H4—liver cancer	0.000692	0.00167	CbGpPWpGaD
Ixabepilone—Myalgia—Doxorubicin—liver cancer	0.000689	0.00118	CcSEcCtD
Ixabepilone—Chest pain—Doxorubicin—liver cancer	0.000689	0.00118	CcSEcCtD
Ixabepilone—Arthralgia—Doxorubicin—liver cancer	0.000689	0.00118	CcSEcCtD
Ixabepilone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.000685	0.00117	CcSEcCtD
Ixabepilone—Anorexia—Epirubicin—liver cancer	0.000681	0.00116	CcSEcCtD
Ixabepilone—TUBB4A—Transmembrane transport of small molecules—SLC11A2—liver cancer	0.000681	0.00165	CbGpPWpGaD
Ixabepilone—TUBB4A—Metabolism of proteins—EXOSC2—liver cancer	0.000672	0.00163	CbGpPWpGaD
Ixabepilone—TUBB2A—Transmembrane transport of small molecules—NR1H4—liver cancer	0.000671	0.00162	CbGpPWpGaD
Ixabepilone—Hypotension—Epirubicin—liver cancer	0.000667	0.00114	CcSEcCtD
Ixabepilone—Oedema—Doxorubicin—liver cancer	0.000661	0.00113	CcSEcCtD
Ixabepilone—CYP3A4—Estrogen metabolism—CYP1A1—liver cancer	0.000657	0.00159	CbGpPWpGaD
Ixabepilone—Infection—Doxorubicin—liver cancer	0.000657	0.00112	CcSEcCtD
Ixabepilone—TUBB1—Transmembrane transport of small molecules—NR1H4—liver cancer	0.000656	0.00159	CbGpPWpGaD
Ixabepilone—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000651	0.00111	CcSEcCtD
Ixabepilone—Shock—Doxorubicin—liver cancer	0.00065	0.00111	CcSEcCtD
Ixabepilone—TUBB4A—Transmembrane transport of small molecules—SLC40A1—liver cancer	0.000649	0.00157	CbGpPWpGaD
Ixabepilone—Nervous system disorder—Doxorubicin—liver cancer	0.000648	0.00111	CcSEcCtD
Ixabepilone—Thrombocytopenia—Doxorubicin—liver cancer	0.000647	0.0011	CcSEcCtD
Ixabepilone—Insomnia—Epirubicin—liver cancer	0.000646	0.0011	CcSEcCtD
Ixabepilone—Skin disorder—Doxorubicin—liver cancer	0.000642	0.00109	CcSEcCtD
Ixabepilone—Paraesthesia—Epirubicin—liver cancer	0.000641	0.00109	CcSEcCtD
Ixabepilone—CYP3A4—Cytochrome P450 - arranged by substrate type—NR1H4—liver cancer	0.000641	0.00155	CbGpPWpGaD
Ixabepilone—Dyspnoea—Epirubicin—liver cancer	0.000637	0.00109	CcSEcCtD
Ixabepilone—Anorexia—Doxorubicin—liver cancer	0.00063	0.00107	CcSEcCtD
Ixabepilone—CYP3A4—Irinotecan Pathway—APC—liver cancer	0.00063	0.00152	CbGpPWpGaD
Ixabepilone—TUBB4B—Transmembrane transport of small molecules—SLC11A2—liver cancer	0.000623	0.00151	CbGpPWpGaD
Ixabepilone—TUBB4A—Transmembrane transport of small molecules—ANXA2—liver cancer	0.000623	0.00151	CbGpPWpGaD
Ixabepilone—TUBB4A—Transmembrane transport of small molecules—ATP7B—liver cancer	0.000623	0.00151	CbGpPWpGaD
Ixabepilone—Decreased appetite—Epirubicin—liver cancer	0.000621	0.00106	CcSEcCtD
Ixabepilone—Hypotension—Doxorubicin—liver cancer	0.000618	0.00105	CcSEcCtD
Ixabepilone—Gastrointestinal disorder—Epirubicin—liver cancer	0.000617	0.00105	CcSEcCtD
Ixabepilone—Fatigue—Epirubicin—liver cancer	0.000616	0.00105	CcSEcCtD
Ixabepilone—TUBB4B—Metabolism of proteins—EXOSC2—liver cancer	0.000615	0.00149	CbGpPWpGaD
Ixabepilone—Constipation—Epirubicin—liver cancer	0.000611	0.00104	CcSEcCtD
Ixabepilone—Pain—Epirubicin—liver cancer	0.000611	0.00104	CcSEcCtD
Ixabepilone—CYP3A4—Xenobiotics—CYP1A1—liver cancer	0.000604	0.00146	CbGpPWpGaD
Ixabepilone—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.000602	0.00103	CcSEcCtD
Ixabepilone—Insomnia—Doxorubicin—liver cancer	0.000598	0.00102	CcSEcCtD
Ixabepilone—TUBB4B—Transmembrane transport of small molecules—SLC40A1—liver cancer	0.000594	0.00144	CbGpPWpGaD
Ixabepilone—Paraesthesia—Doxorubicin—liver cancer	0.000593	0.00101	CcSEcCtD
Ixabepilone—Dyspnoea—Doxorubicin—liver cancer	0.000589	0.001	CcSEcCtD
Ixabepilone—TUBB4A—Transmembrane transport of small molecules—NR1H4—liver cancer	0.000589	0.00142	CbGpPWpGaD
Ixabepilone—Gastrointestinal pain—Epirubicin—liver cancer	0.000584	0.000996	CcSEcCtD
Ixabepilone—CYP3A4—Tamoxifen metabolism—CYP1A1—liver cancer	0.000581	0.00141	CbGpPWpGaD
Ixabepilone—Decreased appetite—Doxorubicin—liver cancer	0.000574	0.000979	CcSEcCtD
Ixabepilone—Gastrointestinal disorder—Doxorubicin—liver cancer	0.000571	0.000973	CcSEcCtD
Ixabepilone—Fatigue—Doxorubicin—liver cancer	0.00057	0.000971	CcSEcCtD
Ixabepilone—TUBB4B—Transmembrane transport of small molecules—ATP7B—liver cancer	0.000569	0.00138	CbGpPWpGaD
Ixabepilone—TUBB4B—Transmembrane transport of small molecules—ANXA2—liver cancer	0.000569	0.00138	CbGpPWpGaD
Ixabepilone—Constipation—Doxorubicin—liver cancer	0.000565	0.000964	CcSEcCtD
Ixabepilone—Pain—Doxorubicin—liver cancer	0.000565	0.000964	CcSEcCtD
Ixabepilone—Body temperature increased—Epirubicin—liver cancer	0.000565	0.000963	CcSEcCtD
Ixabepilone—Abdominal pain—Epirubicin—liver cancer	0.000565	0.000963	CcSEcCtD
Ixabepilone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—liver cancer	0.00055	0.00133	CbGpPWpGaD
Ixabepilone—Gastrointestinal pain—Doxorubicin—liver cancer	0.00054	0.000921	CcSEcCtD
Ixabepilone—TUBB4B—Transmembrane transport of small molecules—NR1H4—liver cancer	0.000538	0.0013	CbGpPWpGaD
Ixabepilone—Hypersensitivity—Epirubicin—liver cancer	0.000526	0.000897	CcSEcCtD
Ixabepilone—Body temperature increased—Doxorubicin—liver cancer	0.000522	0.000891	CcSEcCtD
Ixabepilone—Abdominal pain—Doxorubicin—liver cancer	0.000522	0.000891	CcSEcCtD
Ixabepilone—CYP3A4—Phase 1 - Functionalization of compounds—NR1H4—liver cancer	0.00052	0.00126	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle, Mitotic—PSMA4—liver cancer	0.000516	0.00125	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle, Mitotic—PSMD10—liver cancer	0.000516	0.00125	CbGpPWpGaD
Ixabepilone—Asthenia—Epirubicin—liver cancer	0.000512	0.000874	CcSEcCtD
Ixabepilone—Pruritus—Epirubicin—liver cancer	0.000505	0.000862	CcSEcCtD
Ixabepilone—Diarrhoea—Epirubicin—liver cancer	0.000489	0.000833	CcSEcCtD
Ixabepilone—Hypersensitivity—Doxorubicin—liver cancer	0.000487	0.00083	CcSEcCtD
Ixabepilone—Asthenia—Doxorubicin—liver cancer	0.000474	0.000808	CcSEcCtD
Ixabepilone—CYP3A4—Biological oxidations—UGDH—liver cancer	0.000473	0.00114	CbGpPWpGaD
Ixabepilone—Dizziness—Epirubicin—liver cancer	0.000472	0.000805	CcSEcCtD
Ixabepilone—Pruritus—Doxorubicin—liver cancer	0.000468	0.000797	CcSEcCtD
Ixabepilone—TUBB—Cell Cycle—PSMD10—liver cancer	0.000461	0.00112	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle—PSMA4—liver cancer	0.000461	0.00112	CbGpPWpGaD
Ixabepilone—TUBB6—Metabolism of proteins—ATF3—liver cancer	0.00046	0.00111	CbGpPWpGaD
Ixabepilone—TUBB2B—Metabolism of proteins—ATF3—liver cancer	0.00046	0.00111	CbGpPWpGaD
Ixabepilone—Vomiting—Epirubicin—liver cancer	0.000454	0.000774	CcSEcCtD
Ixabepilone—Diarrhoea—Doxorubicin—liver cancer	0.000452	0.000771	CcSEcCtD
Ixabepilone—Rash—Epirubicin—liver cancer	0.00045	0.000768	CcSEcCtD
Ixabepilone—Dermatitis—Epirubicin—liver cancer	0.00045	0.000767	CcSEcCtD
Ixabepilone—Headache—Epirubicin—liver cancer	0.000447	0.000763	CcSEcCtD
Ixabepilone—TUBB3—Metabolism of proteins—ATF3—liver cancer	0.000444	0.00107	CbGpPWpGaD
Ixabepilone—Dizziness—Doxorubicin—liver cancer	0.000437	0.000745	CcSEcCtD
Ixabepilone—CYP3A4—Tryptophan metabolism—CYP2E1—liver cancer	0.000432	0.00104	CbGpPWpGaD
Ixabepilone—TUBB2A—Metabolism of proteins—ATF3—liver cancer	0.00043	0.00104	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle, Mitotic—PSMD10—liver cancer	0.000428	0.00103	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle, Mitotic—PSMA4—liver cancer	0.000428	0.00103	CbGpPWpGaD
Ixabepilone—Nausea—Epirubicin—liver cancer	0.000424	0.000723	CcSEcCtD
Ixabepilone—TUBB1—Metabolism of proteins—ATF3—liver cancer	0.00042	0.00102	CbGpPWpGaD
Ixabepilone—Vomiting—Doxorubicin—liver cancer	0.00042	0.000716	CcSEcCtD
Ixabepilone—Rash—Doxorubicin—liver cancer	0.000417	0.00071	CcSEcCtD
Ixabepilone—Dermatitis—Doxorubicin—liver cancer	0.000416	0.00071	CcSEcCtD
Ixabepilone—Headache—Doxorubicin—liver cancer	0.000414	0.000706	CcSEcCtD
Ixabepilone—Nausea—Doxorubicin—liver cancer	0.000393	0.000669	CcSEcCtD
Ixabepilone—TUBB4B—Cell Cycle, Mitotic—PSMA4—liver cancer	0.000391	0.000946	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle, Mitotic—PSMD10—liver cancer	0.000391	0.000946	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle—PSMA4—liver cancer	0.000382	0.000924	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle—PSMD10—liver cancer	0.000382	0.000924	CbGpPWpGaD
Ixabepilone—TUBB4A—Metabolism of proteins—ATF3—liver cancer	0.000377	0.000913	CbGpPWpGaD
Ixabepilone—TUBB6—Transmembrane transport of small molecules—CYCS—liver cancer	0.000365	0.000884	CbGpPWpGaD
Ixabepilone—TUBB2B—Transmembrane transport of small molecules—CYCS—liver cancer	0.000365	0.000884	CbGpPWpGaD
Ixabepilone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—liver cancer	0.000362	0.000874	CbGpPWpGaD
Ixabepilone—TUBB3—Transmembrane transport of small molecules—CYCS—liver cancer	0.000353	0.000853	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle—PSMD10—liver cancer	0.00035	0.000846	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle—PSMA4—liver cancer	0.00035	0.000846	CbGpPWpGaD
Ixabepilone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—liver cancer	0.000349	0.000845	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle, Mitotic—H2AFX—liver cancer	0.000349	0.000843	CbGpPWpGaD
Ixabepilone—TUBB4B—Metabolism of proteins—ATF3—liver cancer	0.000345	0.000835	CbGpPWpGaD
Ixabepilone—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—liver cancer	0.000345	0.000834	CbGpPWpGaD
Ixabepilone—TUBB2A—Transmembrane transport of small molecules—CYCS—liver cancer	0.000342	0.000827	CbGpPWpGaD
Ixabepilone—TUBB1—Transmembrane transport of small molecules—CYCS—liver cancer	0.000334	0.000808	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle, Mitotic—PCNA—liver cancer	0.000326	0.000789	CbGpPWpGaD
Ixabepilone—TUBB2B—Transmembrane transport of small molecules—HMOX1—liver cancer	0.000318	0.000768	CbGpPWpGaD
Ixabepilone—TUBB6—Transmembrane transport of small molecules—HMOX1—liver cancer	0.000318	0.000768	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle—H2AFX—liver cancer	0.000312	0.000754	CbGpPWpGaD
Ixabepilone—CYP3A4—Tryptophan metabolism—CYP1A1—liver cancer	0.00031	0.000751	CbGpPWpGaD
Ixabepilone—TUBB3—Transmembrane transport of small molecules—HMOX1—liver cancer	0.000307	0.000742	CbGpPWpGaD
Ixabepilone—TUBB4A—Transmembrane transport of small molecules—CYCS—liver cancer	0.0003	0.000726	CbGpPWpGaD
Ixabepilone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—liver cancer	0.000299	0.000723	CbGpPWpGaD
Ixabepilone—TUBB2A—Transmembrane transport of small molecules—HMOX1—liver cancer	0.000297	0.000719	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle—PCNA—liver cancer	0.000292	0.000706	CbGpPWpGaD
Ixabepilone—TUBB1—Transmembrane transport of small molecules—HMOX1—liver cancer	0.000291	0.000703	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle, Mitotic—H2AFX—liver cancer	0.000289	0.000698	CbGpPWpGaD
Ixabepilone—TUBB6—Metabolism of proteins—IGF2—liver cancer	0.000285	0.000689	CbGpPWpGaD
Ixabepilone—TUBB2B—Metabolism of proteins—IGF2—liver cancer	0.000285	0.000689	CbGpPWpGaD
Ixabepilone—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—liver cancer	0.000283	0.000685	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle—TERT—liver cancer	0.000282	0.000682	CbGpPWpGaD
Ixabepilone—CYP3A4—Biological oxidations—NR1H4—liver cancer	0.000276	0.000668	CbGpPWpGaD
Ixabepilone—TUBB3—Metabolism of proteins—IGF2—liver cancer	0.000275	0.000665	CbGpPWpGaD
Ixabepilone—TUBB4B—Transmembrane transport of small molecules—CYCS—liver cancer	0.000274	0.000664	CbGpPWpGaD
Ixabepilone—CYP3A4—Biological oxidations—GSTA3—liver cancer	0.000271	0.000656	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle, Mitotic—PCNA—liver cancer	0.00027	0.000654	CbGpPWpGaD
Ixabepilone—CYP3A4—Metapathway biotransformation—GSTA3—liver cancer	0.000268	0.000647	CbGpPWpGaD
Ixabepilone—TUBB2A—Metabolism of proteins—IGF2—liver cancer	0.000266	0.000644	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle, Mitotic—H2AFX—liver cancer	0.000264	0.000639	CbGpPWpGaD
Ixabepilone—TUBB4A—Transmembrane transport of small molecules—HMOX1—liver cancer	0.000261	0.000631	CbGpPWpGaD
Ixabepilone—TUBB1—Metabolism of proteins—IGF2—liver cancer	0.00026	0.00063	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle—H2AFX—liver cancer	0.000258	0.000624	CbGpPWpGaD
Ixabepilone—TUBB6—Transmembrane transport of small molecules—PPARA—liver cancer	0.000257	0.000621	CbGpPWpGaD
Ixabepilone—TUBB2B—Transmembrane transport of small molecules—PPARA—liver cancer	0.000257	0.000621	CbGpPWpGaD
Ixabepilone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—liver cancer	0.000251	0.000607	CbGpPWpGaD
Ixabepilone—CYP3A4—Biological oxidations—GSTA4—liver cancer	0.000248	0.0006	CbGpPWpGaD
Ixabepilone—TUBB3—Transmembrane transport of small molecules—PPARA—liver cancer	0.000248	0.000599	CbGpPWpGaD
Ixabepilone—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—liver cancer	0.000248	0.000599	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle, Mitotic—PCNA—liver cancer	0.000247	0.000598	CbGpPWpGaD
Ixabepilone—CYP3A4—Metapathway biotransformation—GSTA4—liver cancer	0.000245	0.000592	CbGpPWpGaD
Ixabepilone—CYP3A4—Biological oxidations—GSTA2—liver cancer	0.000242	0.000585	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle—PCNA—liver cancer	0.000242	0.000585	CbGpPWpGaD
Ixabepilone—TUBB2A—Transmembrane transport of small molecules—PPARA—liver cancer	0.00024	0.00058	CbGpPWpGaD
Ixabepilone—TUBB4B—Transmembrane transport of small molecules—HMOX1—liver cancer	0.000239	0.000577	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle—H2AFX—liver cancer	0.000236	0.000571	CbGpPWpGaD
Ixabepilone—TUBB1—Transmembrane transport of small molecules—PPARA—liver cancer	0.000235	0.000568	CbGpPWpGaD
Ixabepilone—TUBB4A—Metabolism of proteins—IGF2—liver cancer	0.000234	0.000566	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle—TERT—liver cancer	0.000234	0.000565	CbGpPWpGaD
Ixabepilone—CYP3A4—Biological oxidations—GSTA1—liver cancer	0.000233	0.000564	CbGpPWpGaD
Ixabepilone—CYP3A4—Biological oxidations—NAT2—liver cancer	0.000231	0.000558	CbGpPWpGaD
Ixabepilone—CYP3A4—Metapathway biotransformation—NAT2—liver cancer	0.000228	0.00055	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle—PCNA—liver cancer	0.000221	0.000535	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle, Mitotic—CDKN2A—liver cancer	0.000216	0.000521	CbGpPWpGaD
Ixabepilone—TUBB4B—Metabolism of proteins—IGF2—liver cancer	0.000214	0.000517	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle—TERT—liver cancer	0.000214	0.000517	CbGpPWpGaD
Ixabepilone—TUBB4A—Transmembrane transport of small molecules—PPARA—liver cancer	0.000211	0.00051	CbGpPWpGaD
Ixabepilone—TUBB2B—Metabolism of proteins—F2—liver cancer	0.000209	0.000505	CbGpPWpGaD
Ixabepilone—TUBB6—Metabolism of proteins—F2—liver cancer	0.000209	0.000505	CbGpPWpGaD
Ixabepilone—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—liver cancer	0.000203	0.000492	CbGpPWpGaD
Ixabepilone—TUBB3—Metabolism of proteins—F2—liver cancer	0.000202	0.000487	CbGpPWpGaD
Ixabepilone—TUBB2A—Metabolism of proteins—F2—liver cancer	0.000195	0.000472	CbGpPWpGaD
Ixabepilone—CYP3A4—Metapathway biotransformation—GPX3—liver cancer	0.000194	0.000468	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle—CDKN2A—liver cancer	0.000193	0.000466	CbGpPWpGaD
Ixabepilone—TUBB4B—Transmembrane transport of small molecules—PPARA—liver cancer	0.000193	0.000466	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle, Mitotic—CDKN1B—liver cancer	0.000191	0.000462	CbGpPWpGaD
Ixabepilone—TUBB1—Metabolism of proteins—F2—liver cancer	0.000191	0.000462	CbGpPWpGaD
Ixabepilone—TUBB2B—Transmembrane transport of small molecules—ALB—liver cancer	0.000191	0.000461	CbGpPWpGaD
Ixabepilone—TUBB6—Transmembrane transport of small molecules—ALB—liver cancer	0.000191	0.000461	CbGpPWpGaD
Ixabepilone—CYP3A4—Biological oxidations—HPGDS—liver cancer	0.000184	0.000446	CbGpPWpGaD
Ixabepilone—TUBB3—Transmembrane transport of small molecules—ALB—liver cancer	0.000184	0.000445	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle, Mitotic—CCND1—liver cancer	0.000182	0.000441	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle, Mitotic—CDKN2A—liver cancer	0.000179	0.000432	CbGpPWpGaD
Ixabepilone—TUBB2A—Transmembrane transport of small molecules—ALB—liver cancer	0.000178	0.000431	CbGpPWpGaD
Ixabepilone—TUBB2B—Metabolism of proteins—MMP2—liver cancer	0.000177	0.000428	CbGpPWpGaD
Ixabepilone—TUBB6—Metabolism of proteins—MMP2—liver cancer	0.000177	0.000428	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle, Mitotic—CDKN1A—liver cancer	0.000176	0.000426	CbGpPWpGaD
Ixabepilone—TUBB1—Transmembrane transport of small molecules—ALB—liver cancer	0.000174	0.000422	CbGpPWpGaD
Ixabepilone—TUBB6—Transmembrane transport of small molecules—RAF1—liver cancer	0.000172	0.000417	CbGpPWpGaD
Ixabepilone—TUBB2B—Transmembrane transport of small molecules—RAF1—liver cancer	0.000172	0.000417	CbGpPWpGaD
Ixabepilone—TUBB4A—Metabolism of proteins—F2—liver cancer	0.000171	0.000414	CbGpPWpGaD
Ixabepilone—TUBB3—Metabolism of proteins—MMP2—liver cancer	0.000171	0.000413	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle—CDKN1B—liver cancer	0.000171	0.000413	CbGpPWpGaD
Ixabepilone—TUBB3—Transmembrane transport of small molecules—RAF1—liver cancer	0.000167	0.000403	CbGpPWpGaD
Ixabepilone—TUBB2A—Metabolism of proteins—MMP2—liver cancer	0.000166	0.0004	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle, Mitotic—CDKN2A—liver cancer	0.000163	0.000395	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle—CCND1—liver cancer	0.000163	0.000394	CbGpPWpGaD
Ixabepilone—TUBB1—Metabolism of proteins—MMP2—liver cancer	0.000162	0.000391	CbGpPWpGaD
Ixabepilone—TUBB2A—Transmembrane transport of small molecules—RAF1—liver cancer	0.000161	0.00039	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle—CDKN2A—liver cancer	0.00016	0.000386	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle, Mitotic—CDKN1B—liver cancer	0.000158	0.000383	CbGpPWpGaD
Ixabepilone—TUBB1—Transmembrane transport of small molecules—RAF1—liver cancer	0.000158	0.000382	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle—CDKN1A—liver cancer	0.000158	0.000381	CbGpPWpGaD
Ixabepilone—TUBB4B—Metabolism of proteins—F2—liver cancer	0.000157	0.000379	CbGpPWpGaD
Ixabepilone—TUBB4A—Transmembrane transport of small molecules—ALB—liver cancer	0.000157	0.000379	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle, Mitotic—CCND1—liver cancer	0.000151	0.000365	CbGpPWpGaD
Ixabepilone—CYP3A4—Biological oxidations—CYP2E1—liver cancer	0.00015	0.000364	CbGpPWpGaD
Ixabepilone—CYP3A4—Metapathway biotransformation—CYP2E1—liver cancer	0.000148	0.000359	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle, Mitotic—MYC—liver cancer	0.000146	0.000353	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle—CDKN2A—liver cancer	0.000146	0.000353	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle, Mitotic—CDKN1A—liver cancer	0.000146	0.000353	CbGpPWpGaD
Ixabepilone—TUBB4A—Metabolism of proteins—MMP2—liver cancer	0.000145	0.000351	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle, Mitotic—CDKN1B—liver cancer	0.000145	0.00035	CbGpPWpGaD
Ixabepilone—TUBB4B—Transmembrane transport of small molecules—ALB—liver cancer	0.000143	0.000346	CbGpPWpGaD
Ixabepilone—TUBB4A—Transmembrane transport of small molecules—RAF1—liver cancer	0.000142	0.000343	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle—CDKN1B—liver cancer	0.000141	0.000342	CbGpPWpGaD
Ixabepilone—CYP3A4—Biological oxidations—GGT1—liver cancer	0.000138	0.000334	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle, Mitotic—CCND1—liver cancer	0.000138	0.000334	CbGpPWpGaD
Ixabepilone—TUBB6—Metabolism of proteins—CTNNB1—liver cancer	0.000136	0.000328	CbGpPWpGaD
Ixabepilone—TUBB2B—Metabolism of proteins—CTNNB1—liver cancer	0.000136	0.000328	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle—CCND1—liver cancer	0.000135	0.000326	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle, Mitotic—CDKN1A—liver cancer	0.000134	0.000323	CbGpPWpGaD
Ixabepilone—TUBB4B—Metabolism of proteins—MMP2—liver cancer	0.000133	0.000321	CbGpPWpGaD
Ixabepilone—TUBB3—Metabolism of proteins—CTNNB1—liver cancer	0.000131	0.000317	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle—MYC—liver cancer	0.000131	0.000316	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle—CDKN1A—liver cancer	0.000131	0.000316	CbGpPWpGaD
Ixabepilone—TUBB4B—Transmembrane transport of small molecules—RAF1—liver cancer	0.00013	0.000313	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle—CDKN1B—liver cancer	0.000129	0.000313	CbGpPWpGaD
Ixabepilone—TUBB2A—Metabolism of proteins—CTNNB1—liver cancer	0.000127	0.000307	CbGpPWpGaD
Ixabepilone—TUBB1—Metabolism of proteins—CTNNB1—liver cancer	0.000124	0.0003	CbGpPWpGaD
Ixabepilone—CYP3A4—Biological oxidations—GSTP1—liver cancer	0.000124	0.0003	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle—CCND1—liver cancer	0.000123	0.000299	CbGpPWpGaD
Ixabepilone—CYP3A4—Metapathway biotransformation—GSTP1—liver cancer	0.000122	0.000296	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle, Mitotic—MYC—liver cancer	0.000121	0.000293	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle—CDKN1A—liver cancer	0.000119	0.000289	CbGpPWpGaD
Ixabepilone—CYP3A4—Biological oxidations—GSTM1—liver cancer	0.000114	0.000276	CbGpPWpGaD
Ixabepilone—CYP3A4—Metapathway biotransformation—GSTM1—liver cancer	0.000112	0.000272	CbGpPWpGaD
Ixabepilone—TUBB4A—Metabolism of proteins—CTNNB1—liver cancer	0.000111	0.000269	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle, Mitotic—MYC—liver cancer	0.000111	0.000268	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle—MYC—liver cancer	0.000108	0.000262	CbGpPWpGaD
Ixabepilone—CYP3A4—Biological oxidations—CYP1A1—liver cancer	0.000108	0.000261	CbGpPWpGaD
Ixabepilone—TUBB—Cell Cycle—TP53—liver cancer	0.000107	0.000259	CbGpPWpGaD
Ixabepilone—CYP3A4—Metapathway biotransformation—CYP1A1—liver cancer	0.000107	0.000258	CbGpPWpGaD
Ixabepilone—TUBB4B—Metabolism of proteins—CTNNB1—liver cancer	0.000102	0.000246	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle—MYC—liver cancer	9.9e-05	0.000239	CbGpPWpGaD
Ixabepilone—TUBB4A—Cell Cycle—TP53—liver cancer	8.89e-05	0.000215	CbGpPWpGaD
Ixabepilone—TUBB4B—Cell Cycle—TP53—liver cancer	8.13e-05	0.000197	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—UGDH—liver cancer	8.08e-05	0.000195	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—EPT1—liver cancer	7.6e-05	0.000184	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—TAT—liver cancer	7.2e-05	0.000174	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—GLUL—liver cancer	4.9e-05	0.000118	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—CPT1B—liver cancer	4.9e-05	0.000118	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—NR1H4—liver cancer	4.72e-05	0.000114	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—GSTA3—liver cancer	4.64e-05	0.000112	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—GSTA4—liver cancer	4.25e-05	0.000103	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—GSTA2—liver cancer	4.14e-05	0.0001	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—GSTA1—liver cancer	3.99e-05	9.65e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—NAT2—liver cancer	3.95e-05	9.54e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—ALDOB—liver cancer	3.78e-05	9.15e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—CRABP1—liver cancer	3.61e-05	8.73e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—HPGDS—liver cancer	3.16e-05	7.63e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—PSMD10—liver cancer	2.81e-05	6.8e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—PSMA4—liver cancer	2.81e-05	6.8e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—GOT2—liver cancer	2.74e-05	6.62e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—CYP2E1—liver cancer	2.57e-05	6.22e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—CYCS—liver cancer	2.41e-05	5.82e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—GGT1—liver cancer	2.36e-05	5.71e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—GOT1—liver cancer	2.36e-05	5.71e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—GSTP1—liver cancer	2.12e-05	5.13e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—HMOX1—liver cancer	2.09e-05	5.06e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—GSTM1—liver cancer	1.95e-05	4.71e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—CYP1A1—liver cancer	1.85e-05	4.47e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—MTHFR—liver cancer	1.72e-05	4.17e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—PPARA—liver cancer	1.69e-05	4.09e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—PIK3CG—liver cancer	1.45e-05	3.5e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—PPARG—liver cancer	1.4e-05	3.38e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—PIK3CD—liver cancer	1.27e-05	3.08e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—ALB—liver cancer	1.26e-05	3.04e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—PIK3CB—liver cancer	1.11e-05	2.68e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—PIK3CA—liver cancer	6.76e-06	1.64e-05	CbGpPWpGaD
Ixabepilone—CYP3A4—Metabolism—AKT1—liver cancer	5.52e-06	1.34e-05	CbGpPWpGaD
